How many drugs treat Aplastic anemia?

Drug Landscape tracks 3 marketed treatments for Aplastic anemia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/aplastic-anemia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Aplastic anemia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aplastic anemia (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Aplastic anemia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Nplate	ROMIPLOSTIM	Amgen	Thrombopoietin Receptor Agonist [EPC]	Thrombopoietin receptor	2008-01-01
Anadrol-50	OXYMETHOLONE	Pharmobedient	oxymetholone	Androgen receptor	1972-01-01
Nplate	Nplate	Nantes University Hospital		Thrombopoietin receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Amgen · 1 drug in Aplastic anemia
Nantes University Hospital · 1 drug in Aplastic anemia
Pfizer Inc. · 1 drug in Aplastic anemia
Pharmobedient · 1 drug in Aplastic anemia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Aplastic anemia:

Cite this brief

Drug Landscape (2026). Aplastic anemia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/aplastic-anemia. Accessed 2026-06-10.

Aplastic anemia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing